Aster DM Healthcare Ltd (ASTERDM) — shareholding pattern, promoter holding, financials and share price
About Aster DM Healthcare Ltd (ASTERDM)
Aster DM Healthcare Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as ASTERDM and on the BSE under scrip code 540975. Its ISIN is INE914M01019.
Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]
Aster DM Healthcare is a prominent healthcare provider across the GCC and India, offering a complete circle of care through hospitals, clinics, labs, and pharmacies.
Aster is experiencing strong sequential revenue growth with a 15% increase YoY in Q3FY26, driven by expanding patient volumes and effective cost management, evidenced by a 22% rise in operating EBITDA.
Listed peers in Hospital: Max Healthcare Institute Ltd, Fortis Healthcare Ltd, Narayana Hrudayalaya Ltd, Global Health Ltd, Krishna Institute of Medical Sciences Ltd, Dr Agarwals Health Care Ltd.
Valuation & Returns
28 Jul 2026At ₹813.6 a share on 28 Jul 2026, Aster DM Healthcare Ltd (ASTERDM) was valued at a price-to-earnings ratio of 166.05x against an industry P/E of 64.49x and a price-to-book of 20.69x on a book value of ₹39.33 per share as of Mar 2025. Solomo computes return on equity of 12.46% and return on capital employed of 12.72% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 166.05x
- Industry P/E
- 64.49x
- P/B
- 20.69x
- EPS (TTM)
- ₹4.9
- Book value / share
- ₹39.33
- ROE
- 12.46%
- ROCE
- 12.72%
- ROA
- 6.46%
- Debt / equity
- 0.59x
- Dividend yield
- 0.49%
- EBITDA margin
- 20.61%
- 52-week range
- ₹519.8 – ₹847.95
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Aster DM Healthcare Ltd (ASTERDM) reported revenue of ₹4,643 crore, net profit of ₹427 crore and earnings per share of ₹7.49. That compares with revenue of ₹4,138 crore and net profit of ₹5,408 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹1,182 crore and net profit ₹154 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 10,253 | 2,994 | 3,699 | 4,138 | 4,643 |
| Net profit (₹ cr) | 601 | 475 | 212 | 5,408 | 427 |
| EPS (₹) | 10.53 | 8.51 | 2.59 | 107.66 | 7.49 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 32.13% | 25.00% | 27.62% | 11.88% |
| Profit growth | - | 152.40% | 309.86% | - |
| Stock price CAGR | - | 39% | 40% | 41% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 40.39% of Aster DM Healthcare Ltd (ASTERDM) (unchanged from the previous quarter), foreign institutional investors (FII) hold 10.53% and domestic institutional investors (DII) hold 27.65%. Promoters have pledged 40.7% of their holding. Market capitalisation was ₹70,919 crore on 28 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2018.
Largest disclosed public shareholders in Jun 2026: HDFC Small Cap Fund 8.66%, Rimco (Mauritius) Limited 6.87%, Kotak Small Cap Fund 4.74%, SBI Contra Fund 2.73%, Bcp Asia Ii Topco Iv Pte.Ltd. 2.69%, Quant Mutual Fund - Quant Small Cap Fund 2.27%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 40.39% | 40.7% | 10.53% | 27.65% | 59.61% |
| Mar 2026 | 40.39% | 40.7% | 17.18% | 27.57% | 59.38% |
| Dec 2025 | 40.39% | 40.7% | 18.46% | 26.12% | 59.38% |
| Sep 2025 | 40.39% | 40.7% | 18.72% | 26.32% | 59.38% |
| Jun 2025 | 40.39% | 40.7% | 19.64% | 25.28% | 59.36% |
| Mar 2025 | 41.89% | 40.7% | 21.66% | 24.59% | 57.85% |
| Dec 2024 | 41.88% | 98.9% | 22.62% | 22.91% | 57.84% |
| Sep 2024 | 41.88% | 98.9% | 23.85% | 20.91% | 57.82% |